BPC-157 and Orforglipron Interaction

Compatible
Researched 90% confidence

BPC-157 and Orforglipron have a compatible interaction with 90% confidence. No known interactions; may support gut health and potentially mitigate GI adverse effects. These compounds primarily affect different organ systems.

Compound Profiles

BPC-157

Body Protection Compound-157 | Pentadecapeptide

Promotes blood vessel formation (angiogenesis), enhances collagen synthesis, modulates growth factor expression including VEGF, and protects against tissue damage through localized or systemic delivery pathways..

Half-life: <30 minutes Typical dose: 250-500mcg healing, longevity
vegf anticoagulantcarcinogenic riskpro angiogenicteratogenic
View full profile

Orforglipron

Oral Small-Molecule GLP-1 Receptor Agonist | Weight Loss & Diabetes

Small-molecule GLP-1 receptor agonist with biased signaling preferentially activating G protein/cAMP pathways, enhancing insulin secretion, suppressing glucagon, delaying gastric emptying, and reducing appetite while minimizing receptor desensitization. 79.

Half-life: 25-68 hours Typical dose: Start 3-6mg daily, titrate up to 12-36mg based on response weight loss, metabolic
glp1 receptor teratogenic
View full profile

Combined Organ Load

Blood Vessels
low
GI Tract
low
Pancreas
low

Shared Safety Flags

2x 2 compounds share the teratogenic safety flag (BPC-157, Orforglipron). Monitor accordingly.

Frequently Asked Questions

Can I take BPC-157 with Orforglipron?

Yes, BPC-157 and Orforglipron can generally be taken together. No known interactions; may support gut health and potentially mitigate GI adverse effects.

Is BPC-157 and Orforglipron safe together?

Based on documented research, this combination is considered compatible. However, shared safety flags include: teratogenic. Monitor accordingly.

What are the interactions between BPC-157 and Orforglipron?

No known interactions; may support gut health and potentially mitigate GI adverse effects. This assessment has 90% confidence and is based on documented research data.

How should I time BPC-157 and Orforglipron?

BPC-157 has a half-life of <30 minutes and Orforglipron has a half-life of 25-68 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: BPC-157 vs Orforglipron

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.